Biortica Agrimed has brought its genetics arm, Apollo Green, to the Australian market, with chief executive Tom Varga saying the move is designed to let cultivators concentrate on growing cannabis rather than navigating the hurdles that typically precede it.
Varga said establishing the operation locally would eliminate obstacles including pheno hunting and the lengthy delays associated with quarantine processes.
"We are proud to introduce Apollo Green's expertise and genetics to Australia," Varga said. "Our mission is to empower Australian cultivators with reliable, high-performing genetics that drive innovation and profitability.
"Apollo Green Australia removes barriers like pheno hunting and quarantine delays, enabling growers to focus on cultivating exceptional cannabis."
He said growers have the option to take on an exclusive genetic and build a brand in Australia "knowing they are protected".
"Already Australian brands are showing strong demand for Apollo Green genetics cultivated in Australia. This is a great win for the industry," Varga added.
Biortica said Apollo Green Australia will give growers access to a library of 900 cultivars and will bring "some of California's most famous phenotypes to Australian soil".
Among its partners are Californian breeders Purple City Genetics and Humboldt Seed Co.
"Active breeding and pheno-hunting programs ensure a continuous supply of elite genetics tailored to market needs and local conditions, providing Australian cultivators with the tools needed for ongoing success," Biortica said in a statement announcing the launch.
"Apollo Green has also pre-cleared all plants through Australia's strict quarantine protocols. This ensures immediate availability for growers, eliminating delays often associated with international imports."
Biortica acquired the genetics business in 2023 in a cash and scrip deal worth around $3m in cash.
